Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksERGO.L Regulatory News (ERGO)

  • There is currently no data for ERGO

Block Listing Six Monthly Return

2 Jan 2019 07:00

RNS Number : 7694L
Ergomed plc
02 January 2019
 

BLOCK LISTING SIX MONTHLY RETURN

 

 

Date: 2 January 2019

 

Name of applicant:

Ergomed plc

Name of scheme:

Ergomed plc Long Term Incentive Plan

Period of return:

From:

2 July 2018

To:

31 December 2018

Balance of unallotted securities under scheme(s) from previous return:

1,800,000 (original admission)

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

nil

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

55,000

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

1,745,000

Number and class of securities originally admitted and the date of admission

1,800,000 ordinary shares of 1p each - 2 July 2018

Total number of securities in issue at the end of the period

45,016,438 ordinary shares of 1p each

 

Name of contact:

Nick Blech - Deputy CFO

Telephone number of contact:

+44 (0)7768 547372

 

 Enquiries:

Ergomed plc

Tel: +44 (0) 1483 503205

Stephen Stamp (Chief Executive Officer)

Stuart Jackson (Chief Financial Officer)

 

Numis Securities Limited

Tel: +44 (0) 20 7260 1000

Michael Meade / Freddie Barnfield (Nominated Adviser)

James Black (Broker)

 

Consilium Strategic Communications - for UK enquiries

Tel: +44 (0) 20 3709 5700

Chris Gardner / Mary-Jane Elliott

Matthew Neal / Olivia Manser

 

ergomed@consilium-comms.com

MC-Services - for Continental European enquiries

Tel: +49 211 5292 5222

Anne Hennecke

 

About Ergomed plc

Ergomed provides specialist services to the pharmaceutical industry spanning all phases of clinical development, post-approval pharmacovigilance and medical information. Ergomed's fast-growing, profitable services offering encompasses a complete suite of specialist pharmacovigilance solutions, integrated under the PrimeVigilance brand, in addition to a full range of high quality contract research and trial management services (CRO). Leveraging its CRO expertise, Ergomed also has a drug development portfolio of co-development partnerships and wholly-owned programmes. For further information, visit: http://ergomedplc.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BLRFEWFWAFASEEE
Date   Source Headline
14th Nov 20237:00 amRNSCancellation - Ergomed plc
13th Nov 20233:30 pmRNSForm 8.3 - ERGO LN
13th Nov 20233:20 pmRNSForm 8.3 - Ergomed plc
13th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
13th Nov 202310:37 amRNSScheme of Arrangement becomes Effective
13th Nov 202310:24 amRNSForm 8.5 (EPT/RI) - Ergomed Plc
13th Nov 20237:30 amRNSSuspension - Ergomed plc
10th Nov 20233:47 pmRNSHolding(s) in Company
10th Nov 20233:30 pmRNSForm 8.3 - ERGO LN
10th Nov 20233:30 pmGNWForm 8.3 - Ergomed plc
10th Nov 20233:29 pmRNSForm 8.3 - Ergomed plc
10th Nov 20233:20 pmRNSForm 8.3 - Ergomed plc
10th Nov 20233:15 pmPRNForm 8.3 - Ergomed Plc
10th Nov 20233:05 pmRNSHolding(s) in Company
10th Nov 202312:05 pmGNWForm 8.3 - Ergomed PLC
10th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
10th Nov 202310:50 amGNWMan Group PLC : Form 8.3 - Ergomed plc
10th Nov 202310:45 amRNSForm 8.3 - Ergomed plc
9th Nov 20233:30 pmGNWForm 8.3 - Ergomed plc
9th Nov 20233:20 pmRNSForm 8.3 - Ergomed plc
9th Nov 20232:27 pmRNSIssue of Equity and Rule 2.9 Announcement
9th Nov 20232:16 pmRNSCourt Sanction of the Scheme of Arrangement
9th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
8th Nov 20236:00 pmRNSErgomed
8th Nov 20233:20 pmRNSForm 8.3 - Ergomed plc
8th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
8th Nov 20238:12 amRNSForm 8.5 (EPT/NON-RI) Ergomed Plc
7th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
6th Nov 20233:30 pmGNWForm 8.3 - Ergomed plc
6th Nov 20233:20 pmRNSForm 8.3 - Ergomed plc
6th Nov 20232:04 pmGNWForm 8.3 - Ergomed Plc
6th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
6th Nov 202311:50 amRNSForm 8.3 - Ergomed plc
6th Nov 20238:34 amRNSForm 8.5 (EPT/NON-RI) Ergomed Plc
3rd Nov 20233:30 pmGNWForm 8.3 - Ergomed plc
3rd Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
3rd Nov 20239:33 amGNWMan Group PLC : Form 8.3 - Ergomed plc
2nd Nov 20233:30 pmGNWForm 8.3 - Ergomed plc
2nd Nov 20233:21 pmRNSStatement re Publication of Finance Documentation
2nd Nov 202312:48 pmGNWForm 8.3 - Ergomed Plc
2nd Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
2nd Nov 202311:45 amRNSForm 8.3 - Ergomed plc
2nd Nov 20237:59 amRNSForm 8.5 (EPT/NON-RI) Ergomed Plc
1st Nov 20233:20 pmRNSForm 8.3 - Ergomed plc
1st Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
1st Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
1st Nov 202311:25 amRNSForm 8.3 - Ergomed plc
1st Nov 20238:50 amRNSForm 8.5 (EPT/NON-RI) Ergomed Plc
1st Nov 20237:00 amRNSIssue of Equity and Rule 2.9 Announcement
31st Oct 20235:09 pmGNWForm 8.3 - Ergomed plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.